Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dearbhla Doherty

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Blood Advances|July 1, 2025
Effect of age on ISTH-BAT scores and Low VWF diagnosis in the Zimmerman ProgramFerdows Atiq, Pamela A Christopherson, Dearbhla Doherty, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 2, 2023
Macrophage Galactose Lectin Contributes to the Regulation of FVIII (Factor VIII) Clearance in Mice-Brief ReportSoracha E Ward, Thomas Guest, Ciara Byrne, et al.
Blood Advances|September 29, 2023
VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusionHelen Fogarty, Azaz Ahmad, Ferdows Atiq, et al.
British Journal of Haematology|May 7, 2021
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysisAlexandros Rampotas, Matthew R Wilson, Oliver Lomas, et al.
Blood|December 24, 2023
Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studiesFerdows Atiq, Robin Blok, Calvin B van Kwawegen, et al.
Journal of Thrombosis and Haemostasis : JTH|February 12, 2023
Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factorEinas Elsheikh, Michelle Lavin, Lilian Antunes Heck, et al.
Blood|April 25, 2025
Clinical phenotype and pathophysiological mechanisms underlying qualitative Low VWFFerdows Atiq, Robin Blok, Calvin van Kwawegen, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Blood Advances|July 1, 2025
Effect of age on ISTH-BAT scores and Low VWF diagnosis in the Zimmerman ProgramFerdows Atiq, Pamela A Christopherson, Dearbhla Doherty, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 2, 2023
Macrophage Galactose Lectin Contributes to the Regulation of FVIII (Factor VIII) Clearance in Mice-Brief ReportSoracha E Ward, Thomas Guest, Ciara Byrne, et al.
Blood Advances|September 29, 2023
VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusionHelen Fogarty, Azaz Ahmad, Ferdows Atiq, et al.
British Journal of Haematology|May 7, 2021
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysisAlexandros Rampotas, Matthew R Wilson, Oliver Lomas, et al.
Blood|December 24, 2023
Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studiesFerdows Atiq, Robin Blok, Calvin B van Kwawegen, et al.
Journal of Thrombosis and Haemostasis : JTH|February 12, 2023
Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factorEinas Elsheikh, Michelle Lavin, Lilian Antunes Heck, et al.
Blood|April 25, 2025
Clinical phenotype and pathophysiological mechanisms underlying qualitative Low VWFFerdows Atiq, Robin Blok, Calvin van Kwawegen, et al.
Pageof 2